 |
Publications
|
Linden A. Adams JL. Improving participant selection in disease management programs: insights gained from propensity score stratification. J Eval Clin Pract.(under review) |
|
Linden A. Sample size in disease management program evaluation: the challenge of demonstrating a statistically significant reduction in admissions. Dis Manag. 2008;11(2):95-101. |
|
Linden A, Adler-Milstein J. Medicare disease management in a policy context. Healt Care Fin Rev. 2008;29(3):1-11. |
|
Rastogi A, Linden A, Nissenson AR. Disease management in chronic kidney disease. Adv Chronic Kidney Dis. 2008;15(1):19-28. |
|
Linden A, Biuso TJ, Gopal A, Barker AF, Cigarroa J, Haranath SP, Rinkevich D, Stajduhar K. Consensus development and application of ICD-9 codes for defining chronic illnesses and their complications. Dis Manage and Healt Outc. 2007;15(5):315-322. |
|
Butterworth S, Linden A, McClay W. Health coaching as an intervention in health management programs. Dis Manage and Healt Outc. 2007;15(5):299-307. |
|
Linden A, Goldberg S. The case-mix of chronic illness hospitalization rates in a managed care population: implications for health management programs. J Eval Clin Pract. 2007;13(6):947-951. |
|
Linden A, Berg GD, Wadhwa S. Evaluation of a Medicaid asthma disease management program. Dis Manage. 2007;10(5):266-272. |
|
Linden A. Use of the total population approach to measure U.S. disease management industry's cost savings: issues and implications. Dis Manage and Healt Outc. 2007;15(1):13-18. |
|
Linden A. Estimating the effect of regression to the mean in health management programs. Dis Manage and Healt Outc. 2007;15(1):7-12. |
|
Biuso TJ, Butterworth S, Linden A. Targeting prediabetes with lifestyle, clinical and behavioral management interventions. Dis Manage. 2007;10(1):6-15. |
|
Linden A, Adams J. Determining if disease management saves money: an introduction to meta-analysis. J Eval Clin Pract. 2007;13(3):400-407. |
|
Linden A. Is Israel ready for disease management? Israel Med Assoc J. 2006;8(10):667-671. |
|
Butterworth S, Linden A, McClay M, Leo MC. The effect of motivational interviewing-based health coaching on employees' physical and mental health status. J Occup Healt Psych. 2006;11(4):358-365. |
|
Linden A. Biuso TJ. In search of financial savings from disease management: Applying the number needed to decrease (NND) analysis to a diabetic population. Dis Manage and Healt Outc. 2006;14(4):197-202. |
|
Linden A, Trochim WMK, Adams J. Evaluating program effectiveness using the regression point displacement design. Eval Health Prof. 2006;29(4):407-423. |
|
Linden A. What will it take for disease management to demonstrate a return on investment? New perspectives on an old theme. Am J Manage Care 2006;12(4):217-222. |
|
Linden A, Butterworth SW, Roberts N. Disease management interventions II: What else is in the black box? Dis Manage. 2006;9(2):73-85. |
|
Linden A. Evaluating the effectiveness of home health as a disease management strategy. Home Health Care Manage & Pract. 2006;18(3):216-222. |
|
Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to the regression-discontinuity design. J Eval Clin Pract. 2006;12(2):124-131. |
|
Linden A. Measuring diagnostic and predictive accuracy in disease management: an introduction to receiver operating characteristic (ROC) analysis. J Eval Clin Pract. 2006;12(2):132-139.
|
|
Linden A, Adams J, Roberts N. Strengthening the case for disease management effectiveness: unhiding the hidden bias. J Eval Clin Pract. 2006;12(2):140-147. |
|
Linden A, Adams J. Evaluating disease management program effectiveness: an introduction to instrumental variables. J Eval Clin Pract. 2006;12(2):148-154. |
|
Linden A, Roberts N. Using visual displays as a tool to demonstrate disease management program effectiveness. Dis Manage. 2005;8(5):301-310. |
|
Linden A, Roberts N. A users guide to the disease management literature: recommendations for reporting and assessing program outcomes. Am J Manage Care.2005;11(2):81-90.
|
|
Linden A, Adams J, Roberts N. Evaluating disease management
program effectiveness: An introduction to the bootstrap technique. Dis Manage and Healt Outc. 2005;13(3):159-167. |
|
Linden
A, Adams J, Roberts N. Using propensity scores to construct
comparable control groups for disease management program evaluation.
Dis Manage and Healt Outc. 2005;13(2):107-127. |
|
Linden A, Adams J, Roberts N. Evaluating disease management
program effectiveness adjusting for enrollment (tenure) and
seasonality. Res Healthc Fin Manage. 2004;9(1):57-68. |
|
Linden
A, Roberts N. Disease management interventions: What’s
in the black box? Dis Manage. 2004;7(4):275-291. |
|
Linden A, Adams J, Roberts N. Evaluating disease management
program effectiveness: An introduction to survival analysis.
Dis Manage. 2004;7(3):180-190. |
|
Linden
A, Adams J, Roberts N. The generalizability of disease management
program results: getting from here to there. Manage Care Interface.
2004;17(7):38-45. |
|
Linden A, Adams J, Roberts N. Using an empirical method for
establishing clinical outcome targets in disease management
programs. Dis Manage. 2004;7(2):93-101. |
|
Linden A, Adams J, Roberts N. Evaluation methods in disease management: determining program effectiveness. Position Paper for the Disease Management Association of America (DMAA). October 2003. |
|
Linden A, Adams J, Roberts N. Evaluating disease management
program effectiveness: An introduction to time series analysis.
Dis Manage. 2003;6(4):243-255. |
|
Linden A, Adams J, Roberts N. An assessment of the total population approach for evaluating disease management program effectiveness. Dis Manage. 2003;6(2): 93-102. |
|
Linden A, Roberts N, Keck K. The complete “how to” guide for selecting a disease management vendor. Dis Manage.
2003;6(1):21-26. |
|
Linden A, Holland GJ, Loy SF, Vincent WJ. A physiological comparison of forward vs reverse wheelchair ergometry. Med Sci Sports Exerc. 1993;25(11):1265-1268. |
| |
|
| |
Book Chapters |
|
Adler-Milstein J, Linden A. The use and evaluation of IT in chronic disease management. In: Ashish D (ed). Handbook of Research on IT Management and Clinical Data Administration in Healthcare.
Hershey, PA:
IGI Publishing; (In Print).
|
|
Linden A. Wilson T, Duncan I, Berg G. Perspectives on assessing outcomes: disease management methods. In: Hay J and Rindress D (eds). Managing disease: a comprehensive guide. Washington DC: DMAA; 2007. pp. 95-113. |
|
Linden A. Pharmaceutical industry research and development.
In: Schweitzer SO. Pharmaceutical economics and policy.
New York: Oxford Press; 1997. pp. 21-41. |
|
Linden A. Pharmaceutical regulation and cost containment.
In: Schweitzer SO. Pharmaceutical economics and policy.
New York: Oxford Press; 1997. pp. 171-193. |
| |
|
| |
Peer-Reviewed Letters-to-the Editor |
|
Linden A. “Truth in advertising.” Health Affairs. 2008;27(5):XX-XXX. Re:
Holmes AM, Ackermann RD, Zillich AJ, Katz BP, Downs SM, Inui TS. "The net fiscal impact of a chronic disease management program: Indiana Medicaid, "Health Affairs. 2008;(3):855–864. |
|
Linden A. “Narrow model.” Health Affairs. 2008;27(3):899-900. Re:
Billings J, Mijanovich T.“Improving the Management of Care for High-Cost Medicaid Patients,” Health Affairs. 2007;26(6):1643–1655. |
|
Wilson T, Linden A. “Measuring diabetes management.” Health Affairs. 2004;23(6):277. Re: Villagra A, Ahmed T. “Effectiveness of a disease management program for patients with diabetes.” Health Affairs. 2004;23(4):255-266. |
|
Linden A, Wilson TW. “Care management for heart failure.” Ann Intern Med. 2005;142 (5):386. Re: DeBusk RF, Miller NH, Parker KM, Bandura A, Kraemer HC, Cher DJ, et al. “Care management for low-risk patients with heart failure: a randomized, controlled trial.” Ann Intern Med. 2004;141:606-13. |
|
Wilson TW, Linden A. “Asthma disease management effectiveness: Were the controls equivalent to the cases?” Am J Manag Care 2005;(3):136. Re: Tinkelman D, Wilson S. Asthma disease management: Regression to the mean or better? Am J Manag Care. 2004;10(12):948-54. |
|
Linden A, Wilson TW. Letter to the editor. Circulation: 2005;112(1):e11. Re: Galbreath A, “Long term healthcare and cost outcomes of disease management in a large, randomized community based population with heart failure” Circulation. 2004;110(23):3518-26. |
|
Wilson TW, Linden A. “Potential bias in ‘controls’ used in a heart failure disease management program.” J Am Geriatr Soc 2005;53(7):1268. Re: Berg GD, Wadhwa S, Johnson AE. “A matched-cohort study of health services utilization and financial outcomes for a heart failure disease-management program in elderly patients.” J Am Geriatr Soc 2004;52:1-7. |
|
Wilson TW, Linden A. “Disease management economic value: Unproven?” Health Affairs. 2005;24(2):566-567. Re:Fireman B, Bartlett J, Selby J. Can disease management reduce health care costs by improving quality? Health Affairs. 2004;23(6):63-75. |
| |
|
Peer-Reviewed
Abstracts |
|
Linden A. Using an empirical method for setting expectations
in quality improvement initiatives. Dis Manage Assoc America,
Annual Meeting, 2003. |
|
Linden A. Using time series analysis for evaluating disease
management program effectiveness. Acad Health Serv Res, Annual
Meeting, 2003. |
|
Linden A. The Development of a comprehensive, yet manageable,
quality improvement program in a managed care organization;
a viable alternative to accreditation? Acad Health Serv Res,
Annual Meeting, 2002. |
|
Roberts N, Linden A, Cotter T, Keck K. Improving disease management
program enrollment through a provider outreach program. Dis
Manage Assoc America, Annual Meeting, 2002. |
|
Linden A, Schweitzer SO. Applying survival analysis to health
risk assessment data to predict time to first hospitalization.
Acad Health Serv Res, Annual Meeting, 2001. |
|
Linden A, Schweitzer SO. A comparison of chest x-ray rates between
physicians who self- refer and those who refer patients out:
a case of inappropriate utilization? Acad Health Serv Res, Annual
Meeting, 2001. |
|
Linden A, Schweitzer SO. The development of an “episode
of care” model for assessing access to care for type II
diabetics in a managed care organization. Acad Health Serv Res,
Annual Meeting, 2001. |
|
Linden A, Schweitzer SO. Using ARIMA modeling for forecasting
bed-days in a Medicare HMO. Acad Health Serv Res, Annual Meeting,
2001. |
|
Linden A, Schweitzer SO. Medicare HMO ambulatory service denials:
determinants and consequences. Acad Health Serv Res, Annual
Meeting, 2000. |
|
Linden A, Schweitzer SO. Unintended effects of Medicare HMO
cost-containment strategies. Acad Health Serv Res, Annual Meeting,
2000. |
|
Linden A, Holland GJ, Loy SF, Vincent WJ. A physiological comparison of forward vs reverse wheelchair ergometry. Med Sci Sports Exerc. 1993;Suppl;25(5):S40. |
|
|
 |
 |
